This book will aim to educate practicing otolaryngologists and trainees in the diverse spectrum of surgical and medical interventions available for recalcitrant CRS, with an emphasis on novel therapeutic modalities. Chronic rhinosinusitis (CRS) represents one of the most common healthcare problems in the United States (US), with 1 in 6 adults affected and 31 million individuals newly diagnosed each year. Over 22 billion dollars are spent annually in US health care expenditures due to the cost of prescription medications, surgical interventions, and loss of productivity. Management of CRS recalcitrant to standard medical and surgical intervention continues to present a challenge for many otolaryngologists. An overall productivity cost of $10000/per patient per year is estimated for those with such refractory CRS. The last decade has seen significant expansion in our treatment armamentarium for such recalcitrant disease. New surgical approaches, minimally invasive techniques, endoscopic instrumentation, technologic innovations, in-office procedures, etc. have been developed. Systemic immunomodulatory biologics and a vast array of topical agents have also been introduced. These novel therapeutic options have been the topic of numerous panel presentations at educational conferences/courses by the co-editors but no textbook to date has been published focusing on this important subject. Chapters addressing operative and clinic procedures will offer accompanying videos depicting surgical techniques in addition to illustrations and step-by-step descriptions. Sections reviewing new technology and medical therapies will also include tables and reviews of the pertinent literature.

 

Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis will serve otolaryngologists and trainees in the most up-to-date techniques both surgical and otherwise to address this pervasive issue. It describes new surgical approaches and recent technologic innovations for management of recalcitrant chronic rhinosinusitis, discuss novel medical therapies including nascent systemic biotherapeutics, immunomodulators, and topical additives to assess their potential role in the treatment of refractory chronic rhinosinusitis, and assist practitioners in understanding the relevant evidence, outcomes, and proper application of each therapeutic modality in patients with recalcitrant chronic rhinosinusitis.

Les mer

Introduction to Recalcitrant CRS.- Surgical Procedures for Recalcitrant CRS.- Revision Sinus Surgery for Refractory Maxillary Sinusitis.- Mega-antrostomy/Endoscopic Medial Maxillectomy.- Endoscopic Denker’s.- Revision Sinus Surgery for Refractory Ethmoid Sinusitis.- Reboot Procedure.- Ethmoid Nasalization.- Revision Sinus Surgery for Refractory Sphenoid Sinusitis.- Sphenoid Draf III.- Revision Sinus Surgery for Refractory Frontal Sinusitis.- Various Draf Procedures (Eloy).- Outside-In Draf III.- In-Office Procedures.- Balloon Sinuplasty.- Polypectomy/Sinus Implantation.- Cryoablation.- Radiofrequency.- In-Office ESS with navigation.- Medical Interventions.- Topical Antibiotic Therapies.- IV Antibiotics.- Topical Steroids (irrigations, exhalation delivery device).- Steroid Eluting-Implants.- Aspirin Desensitization.- Leukotriene Modifiers.- Biologics.

Les mer

This book educates practicing otolaryngologists and trainees in the diverse spectrum of surgical and medical interventions available for recalcitrant CRS, with an emphasis on novel therapeutic modalities. Chronic rhinosinusitis (CRS) represents one of the most common healthcare problems in the United States (US), with 1 in 6 adults affected and 31 million individuals newly diagnosed each year. Over 22 billion dollars are spent annually in US health care expenditures due to the cost of prescription medications, surgical interventions, and loss of productivity. Management of CRS recalcitrant to standard medical and surgical intervention continues to present a challenge for many otolaryngologists. An overall productivity cost of $10000/per patient per year is estimated for those with such refractory CRS. The last decade has seen significant expansion in treatment armamentarium for such recalcitrant disease. Systemic immunomodulatory biologics and a vast array of topical agents have also been introduced.

Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis serves otolaryngologists and trainees in the most up-to-date techniques both surgical and otherwise to address this pervasive issue. It describes new surgical approaches and recent technologic innovations for management of recalcitrant chronic rhinosinusitis, discusses novel medical therapies including nascent systemic biotherapeutics, immunomodulators, and topical additives to assess their potential role in the treatment of refractory chronic rhinosinusitis, and assists practitioners in understanding the relevant evidence, outcomes, and proper application of each therapeutic modality in patients with recalcitrant chronic rhinosinusitis. Chapters addressing operative and clinic procedures will offer accompanying videos depicting surgical techniques in addition to illustrations and step-by-step descriptions.

Les mer
Guides novel surgical procedures never before described in one publication Includes narrated surgical instructional videos Provides rhinology and allergy contributions, incorporating reviews of systemic biologic and topical therapies
Les mer
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Produktdetaljer

ISBN
9783031891908
Publisert
2025-08-15
Utgiver
Vendor
Springer International Publishing AG
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet

Om bidragsyterne

Jivianne T. Lee, MD FACS

Professor

Rhinology & Endoscopic Skull Base Surgery

Department of Head & Neck Surgery

University of California Los Angeles David Geffen School of Medicine

 

​Peter Hwang, MD

Stanford University

 

Joseph K.  Han, MD

East Virginia Medical School

 

Jakob L. Fischer, MD

Rhinology and Endoscopic Skull Base Surgery

UCLA Department of Head and Neck Surgery

Los Angeles, California, USA

 

Scott Stringer, MD

Virginia Commonwealth University School of Medicine

Otolaryngology-Head and Neck Surgery